Della Grace Thomas Parambi

1.7k total citations
60 papers, 1.3k citations indexed

About

Della Grace Thomas Parambi is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Della Grace Thomas Parambi has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 24 papers in Pharmacology and 16 papers in Molecular Biology. Recurrent topics in Della Grace Thomas Parambi's work include Synthesis and biological activity (16 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Della Grace Thomas Parambi is often cited by papers focused on Synthesis and biological activity (16 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Della Grace Thomas Parambi collaborates with scholars based in Saudi Arabia, India and Egypt. Della Grace Thomas Parambi's co-authors include Bijo Mathew, Githa Elizabeth Mathew, Hoon Kim, Seetha Harilal, Rajesh Kumar, Md. Sahab Uddin, Jobin Jose, Akash Marathakam, M.K. Unnikrishnan and Lotfi Aleya and has published in prestigious journals such as Scientific Reports, RSC Advances and Environmental Science and Pollution Research.

In The Last Decade

Della Grace Thomas Parambi

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Della Grace Thomas Parambi Saudi Arabia 18 458 406 370 207 165 60 1.3k
Githa Elizabeth Mathew India 26 731 1.6× 704 1.7× 443 1.2× 271 1.3× 162 1.0× 48 1.7k
K. A. PETROV Russia 25 654 1.4× 425 1.0× 558 1.5× 240 1.2× 113 0.7× 140 1.8k
Piera Sozio Italy 29 287 0.6× 261 0.6× 593 1.6× 73 0.4× 111 0.7× 52 1.8k
Paolo Guglielmi Italy 23 439 1.0× 300 0.7× 458 1.2× 90 0.4× 96 0.6× 43 1.2k
Saripella Srikrishna India 23 404 0.9× 213 0.5× 526 1.4× 134 0.6× 136 0.8× 71 1.7k
Paweł Szymański Poland 20 424 0.9× 448 1.1× 482 1.3× 442 2.1× 138 0.8× 86 1.6k
İpek Baysal Türkiye 16 321 0.7× 312 0.8× 210 0.6× 107 0.5× 41 0.2× 45 829
Bhupinder Kumar India 30 1.3k 2.8× 520 1.3× 653 1.8× 367 1.8× 64 0.4× 93 2.3k
Geewoo Nam South Korea 15 150 0.3× 268 0.7× 210 0.6× 182 0.9× 102 0.6× 21 946
Ashraf Khalil Qatar 17 340 0.7× 163 0.4× 641 1.7× 84 0.4× 50 0.3× 37 1.2k

Countries citing papers authored by Della Grace Thomas Parambi

Since Specialization
Citations

This map shows the geographic impact of Della Grace Thomas Parambi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Della Grace Thomas Parambi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Della Grace Thomas Parambi more than expected).

Fields of papers citing papers by Della Grace Thomas Parambi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Della Grace Thomas Parambi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Della Grace Thomas Parambi. The network helps show where Della Grace Thomas Parambi may publish in the future.

Co-authorship network of co-authors of Della Grace Thomas Parambi

This figure shows the co-authorship network connecting the top 25 collaborators of Della Grace Thomas Parambi. A scholar is included among the top collaborators of Della Grace Thomas Parambi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Della Grace Thomas Parambi. Della Grace Thomas Parambi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malebari, Azizah M., Mohamed A. M. Ali, Arafa Musa, et al.. (2025). From chemistry to targeted cancer therapy: potent benzimidazole-1,2,3-triazole hybrid-loaded nanogels against breast and colorectal malignancies. RSC Advances. 15(55). 47601–47618. 1 indexed citations
2.
Prabhakaran, Prabitha, et al.. (2024). New class of thio/semicarbazide-based benzyloxy derivatives as selective class of monoamine oxidase-B inhibitors. Scientific Reports. 14(1). 31292–31292. 1 indexed citations
3.
Yasin, Haya, Ankita Patel, Della Grace Thomas Parambi, et al.. (2024). Recent Progress in Synthetic and Natural Catechol-O-methyltransferase Inhibitors for Neurological Disorders. ACS Omega. 9(44). 44005–44018. 2 indexed citations
4.
Ghoneim, Mohammed M., Mohamed A. Abdelgawad, Nadia A. A. Elkanzi, et al.. (2024). A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives. Archiv der Pharmazie. 357(8). e2400057–e2400057. 17 indexed citations
5.
Jose, Jobin, Jobin Jose, Della Grace Thomas Parambi, et al.. (2024). Opportunities and Regulatory Challenges of Functional Foods andNutraceuticals During COVID-19 Pandemic. Current Nutrition & Food Science. 20(10). 1252–1271.
6.
Musa, Arafa, Saleh Ihmaid, David L. Hughes, et al.. (2023). The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations. Journal of Biomolecular Structure and Dynamics. 41(21). 12411–12425. 33 indexed citations
7.
Al‐Sanea, Mohammad M., Abdelrahman Hamdi, Abdullah A. Elgazar, et al.. (2023). New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2166036–2166036. 37 indexed citations
8.
Almaghrabi, Mohammed, Arafa Musa, Hany E. A. Ahmed, et al.. (2023). Introducing of novel class of pyrano[2,3- c ]pyrazole-5-carbonitrile analogs with potent antimicrobial activity, DNA gyrase inhibition, and prominent pharmacokinetic and CNS toxicity profiles supported by molecular dynamic simulation. Journal of Biomolecular Structure and Dynamics. 42(18). 9529–9546. 11 indexed citations
9.
Parambi, Della Grace Thomas, Jong‐Min Oh, Sunil Kumar, et al.. (2023). Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease: Synthesis, biochemistry, and molecular dynamics study. Computational Biology and Chemistry. 105. 107899–107899. 7 indexed citations
10.
Abdelgawad, Mohamed A., Jong‐Min Oh, Della Grace Thomas Parambi, et al.. (2022). Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease. Journal of Molecular Structure. 1266. 133545–133545. 39 indexed citations
11.
Musa, Arafa, Mohamed A. Abdelgawad, Mohamed E. Shaker, et al.. (2022). Screening and Molecular Docking of Bioactive Metabolites of the Red Sea Sponge Callyspongia siphonella as Potential Antimicrobial Agents. Antibiotics. 11(12). 1682–1682. 3 indexed citations
12.
Abdelgawad, Mohamed A., Arafa Musa, Atiah H. Almalki, et al.. (2021). Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights. Drug Design Development and Therapy. Volume 15. 2325–2337. 35 indexed citations
13.
Parambi, Della Grace Thomas, Khalid Saad Alharbi, Rajesh Kumar, et al.. (2021). Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases. Molecular Neurobiology. 59(1). 191–233. 45 indexed citations
14.
Parambi, Della Grace Thomas, Jong‐Min Oh, Seung Cheol Baek, et al.. (2019). Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. Bioorganic Chemistry. 93. 103335–103335. 59 indexed citations
15.
Parambi, Della Grace Thomas, et al.. (2015). Estimation of Olmesartan Medoxomil, an angiotensin receptor blocker in pharmaceutical dosage form by U.V.Spectrophotometric method. Journal of Pharmacy Research. 1706–1708.
16.
Parambi, Della Grace Thomas, et al.. (2011). Quantitative analysis of valsartan in tablets formulations by high performance thin-layer chromatography. Journal of Applied Pharmaceutical Science. 1. 3 indexed citations
17.
Parambi, Della Grace Thomas, et al.. (2011). A validated stability indicating HPLC method for the determination of Valsartan in tablet dosage forms.. Journal of Applied Pharmaceutical Science. 1. 10 indexed citations
18.
Parambi, Della Grace Thomas, et al.. (2011). ESTIMATION OF PALONOSETRON HYDROCHLORIDE (A 5-HT3 ANTAGONIST) IN PHARMACEUTICAL DOSAGE FORM BY U.V. SPECTROPHOTOMETRIC METHOD. International Journal of Chemical Sciences. 9(4). 1619–1624. 3 indexed citations
19.
Parambi, Della Grace Thomas, et al.. (2010). A validated U.V. spectrophotometric determination of an antihypertensive drug - Nebivolol from tablet formulations. International Journal of Pharmaceutical Sciences Review and Research. 3. 3 indexed citations
20.
Parambi, Della Grace Thomas, et al.. (2010). A VALIDATED HPTLC DETERMINATION OF AN ANGIOTENSIN RECEPTOR BLOCKER OLMESARTAN MEDOXOMIL FROM TABLET DOSAGE FORM.. International Journal of Pharmaceutical Sciences Review and Research. 4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026